Skip to main content
[Preprint]. 2023 Feb 15:rs.3.rs-2489562. [Version 1] doi: 10.21203/rs.3.rs-2489562/v1

Figure 3. Expression of EMT and proliferation markers.

Figure 3

(A) Representative immunohistochemistry staining of E-cadherin and the analysis of its aberrant expression associated with HES1 (−) CRCs. (B-D) Representative immunohistochemistry staining of Ki67 (B), RB1 (C) and Cyclin D1 (D). Differential IHC scores were shown below. (E) Poor prognosis associated with low HES1 expression in TCGA CRC dataset.